Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study - Wikidata - awgldk - TriplyDB

Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study

Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study

http://www.wikidata.org/entity/Q34258327

about

Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson disease Milestones in clinical neurophysiology.Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease Noninvasive brain stimulation treatments for addiction and major depression Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease.Analysis of variance in neuroreceptor ligand imaging studies.Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.Transcranial direct current stimulation for the treatment of Parkinson's disease Transcranial magnetic stimulation and connectivity mapping: tools for studying the neural bases of brain disorders.Combining functional imaging with brain stimulation in Parkinson's disease.Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study.Non-invasive brain stimulation for Parkinson's disease: Current concepts and outlook 2015.[Transcranial magnetic stimulation (TMS) in basic and clinical neuroscience research].Treatment of Parkinson's disease by cortical stimulation.The corticostriatal and corticosubthalamic pathways: two entries, one target. So what?Imaging insights into basal ganglia function, Parkinson's disease, and dystonia Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's disease Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.Levodopa increases memory encoding and dopamine release in the striatum in the elderly.Characteristics of the sequence effect in Parkinson's disease Probing the frontostriatal loops involved in executive and limbic processing via interleaved TMS and functional MRI at two prefrontal locations: a pilot study.Noninvasive brain stimulation for Parkinson's disease and dystonia.Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.The dopaminergic basis of human behaviors: A review of molecular imaging studies.Copper and copper proteins in Parkinson's disease.Transcranial magnetic stimulation at the interface with other techniques: a powerful tool for studying the human cortex.Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging.Striatal Dopamine and the Interface between Motivation and Cognition Do studies on cortical plasticity provide a rationale for using non-invasive brain stimulation as a treatment for Parkinson's disease patients?Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature.The heart side of brain neuromodulation.Differential Associations between Cortical Thickness and Striatal Dopamine in Treatment-Naïve Adults with ADHD vs. Healthy Controls.Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study.Spatial remapping of cortico-striatal connectivity in Parkinson's disease.

P2860

Q26865819-AF5277DD-0624-4838-960A-8701E27C0D8F Q28475974-E2277B84-EFBD-42C9-9F3A-A88DB9AA63A2 Q30430537-8A867D05-25EC-4D18-87C7-D6DCD827EEB8 Q30468145-4B555683-1CAE-41C4-B5AC-398322FDA444 Q30470467-1B099A7C-8F44-4682-87FA-78FAF5CD72BB Q31043230-72FD5631-FF19-4086-A87F-BD53782BBB73 Q33849031-01BAA7FB-C201-4F36-A924-A3DFA607E52F Q33999407-2BFEF994-848D-4FB2-9D39-B25BD45590CE Q34083371-AE0BD21E-4EC4-4EAF-A52A-0EF7D01C4B0A Q34173257-19FBCEB3-B6F3-4D6D-B1BD-6F7DAA06B6A7 Q34179187-C73DEDD4-293D-4836-B063-3DC95257AA59 Q34243081-0F642BB5-65E5-4844-A211-0C922E6A9D01 Q34258312-A3244AA6-7F5A-4A1E-97FE-962031393ECC Q34258319-D3C42F5F-07D1-4197-82D7-A06B63AC1266 Q34258335-F3519625-4D56-4AB3-8F17-6088F9E0D716 Q34495843-082A1742-6084-4035-B8AF-EE9BD8DDE00C Q34976531-DC719AD4-1B77-492A-8212-93044950AE7A Q35015442-1D73959B-631A-4E69-8714-05AB5C5B5831 Q35146020-9475E161-A10F-4D57-8ED8-D0113575CD46 Q35193033-6E2C968C-BC59-4423-AF4B-64E8FECE519A Q35269971-6BA69954-0B30-4AED-9AF6-568EFD498395 Q35680233-16483407-8E47-49E0-ADD7-1446E97F054F Q36553302-65223F63-9D2C-4E9D-BFB6-5631B54D6028 Q36571098-47311E08-3C35-406C-BF7E-759D745C547D Q36663013-2BF93293-66C3-4D25-9024-1D6E5D4AFD96 Q36997368-373E2D90-A543-40D1-B305-A4D843ACC774 Q37131286-11441254-A959-47C5-ABF8-80AA9923A084 Q37385099-E15B3449-8522-495D-AB83-3F37B1E9F9E3 Q37500893-BC2CEFCA-45BE-4C11-9654-6485C65980AA Q37616391-96CA5162-D083-41B2-8864-2B40806AC686 Q37839540-DCED4D88-FC7F-4FEE-84E7-C667936BBA02 Q37871233-6EB42C15-B63E-4BFB-ADFF-9F2AE06FD91E Q37909949-36F076F2-7432-4AAF-B022-C3BD15DA0686 Q38162220-89DF6E40-813D-4E95-AA7B-A8497A324CAB Q38209988-A8B64C05-E3F7-4E7E-BB2B-6F4BF96B984C Q38383080-23ACF01C-79E1-43D0-A853-10BBE42ED71A Q38798206-C0CE9929-08B5-4AE0-B97B-4152BA4CF7CB Q41527108-CE603D00-1469-4FF8-9D89-98C18920EFDD Q42366582-20794441-252D-48E5-B9C5-6B55CC685923 Q43285295-92DD1675-EED5-4D86-B0D7-942D002AAFAE

P2860

Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study

http://www.wikidata.org/entity/Q34258327

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@ast

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@en

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@nl

type

label

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@ast

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@en

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@nl

prefLabel

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@ast

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@en

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@nl

P1433

Q34258327-A7205E69-84D2-40ED-840C-84A0A0278AB9

P1476

Q34258327-CFDEB5B9-4132-4B44-9741-3B01E1B0815A

P2093

Q34258327-282F0588-B57D-4180-B023-F88772880D34

Q34258327-500CE656-EB79-4A0A-921D-93DE6B92B55A

P2860

Q34258327-01D9DFD9-C672-404C-9EAD-BB09AE1D53CD

Q34258327-0EF2C521-CA29-4AD6-A8D1-88015A8E8825

Q34258327-16DD3EBF-CC9C-49EF-BE05-7709B63935BA

Q34258327-1800A735-7E38-4B98-B5D4-214DC4BAAA3D

Q34258327-1FD0D31F-4744-4B2C-B848-C767B080C5FB

Q34258327-25AADF45-4F0B-46B3-AB43-3C9B333DDD05

Q34258327-25D0AD1D-D53E-4EDF-AB86-DE8892D51201

Q34258327-276A80BC-6BED-4C1F-AA24-920FEC319390

Q34258327-2CC4F8EC-B4E9-4122-9F57-CE53B266359E

Q34258327-2F76E142-732A-498B-AE30-B3F46B89A788

P304

Q34258327-DFAFD16E-048C-4810-BDA1-F36ECADD9E11

P31

Q34258327-F44A88F3-1CD3-46B1-B5B2-AD8092F7262C

P356

Q34258327-10228B58-ED88-4B77-85CA-65844D61D934

P407

Q34258327-957ABAE1-AE14-4F10-8F8A-3C8B0CF92C54

P433

Q34258327-BD3A919C-0A6E-43F1-9650-CEDA0F591BC7

P478

Q34258327-7D950206-5E96-4859-99BF-EFD76FD263C6

P50

Q34258327-6168B665-12DA-4BD0-9ABB-3465317976F0

Q34258327-A3B0B1DE-8FF5-4EB4-95DC-57B71BEAE0D7

Q34258327-FFB8F1D4-6993-40B1-B7FC-F9CE7F39CEC0

P577

Q34258327-37E6F798-C3BB-461D-91F3-82F01A5A4B02

P5875

Q34258327-9BD6E5E5-FB7F-4FA9-A8B5-2253B267C7F1

P698

Q34258327-0D73AED1-65E5-44D1-A80C-2CCB70455806

P921

Q34258327-990075EA-A5C7-4F58-9533-2094ABEBB955

P932

Q34258327-C81B7CDC-B6F1-4E4C-815C-57B45505149F

P356

J.1460-9568.2005.04476.X

P1433

European Journal of Neuroscience

P1476

Corticostriatal functional int ...... rTMS/[11C]raclopride PET study

@en

P2093

Maria Fraraccio

http://www.w3.org/2001/XMLSchema#string

Oury Monchi

http://www.w3.org/2001/XMLSchema#string

P2860

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

A statistical method for the analysis of positron emission tomography neuroreceptor ligand data.

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.

Dopamine-mediated regulation of striatal neuronal and network interactions.

Electrophysiology of dopamine in normal and denervated striatal neurons.

Dopamine receptors in Parkinson's disease: imaging studies.

The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns.

Neurodegenerative movement disorders: the contribution of functional imaging.

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

P304

2946-2952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1460-9568.2005.04476.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Antonio P Strafella

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7445314

http://www.w3.org/2001/XMLSchema#string

P698

16324129

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2967526

http://www.w3.org/2001/XMLSchema#string